LINCOLN NATIONAL CORP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$465,835
-5.8%
13,034
-0.5%
0.01%
-9.1%
Q4 2022$494,749
-12.7%
13,099
+2.1%
0.01%
-21.4%
Q3 2022$567,000
+15.5%
12,830
-3.3%
0.01%
+27.3%
Q2 2022$491,0000.0%13,2610.0%0.01%
+10.0%
Q1 2022$491,000
+14.7%
13,261
-5.7%
0.01%
+11.1%
Q4 2021$428,000
-10.6%
14,070
-1.4%
0.01%
-18.2%
Q3 2021$479,000
-20.3%
14,270
-5.3%
0.01%
-15.4%
Q2 2021$601,000
-13.5%
15,070
-2.6%
0.01%
-23.5%
Q1 2021$695,000
-28.1%
15,465
-9.6%
0.02%
-34.6%
Q4 2020$967,000
+19.1%
17,1050.0%0.03%
+8.3%
Q3 2020$812,000
-20.5%
17,105
-1.2%
0.02%
-27.3%
Q2 2020$1,021,000
+22.9%
17,317
-1.5%
0.03%
+6.5%
Q1 2020$831,000
-25.5%
17,572
-4.9%
0.03%
-13.9%
Q4 2019$1,116,000
+3.6%
18,474
+2.8%
0.04%
-10.0%
Q3 2019$1,077,000
-3.8%
17,974
+3.1%
0.04%
-7.0%
Q2 2019$1,120,000
-28.2%
17,431
-9.3%
0.04%
-33.8%
Q1 2019$1,560,000
+69.0%
19,218
+12.5%
0.06%
+54.8%
Q4 2018$923,000
-6.5%
17,081
-10.8%
0.04%
+27.3%
Q3 2018$987,000
+46.4%
19,141
+18.3%
0.03%
+32.0%
Q2 2018$674,000
+21.7%
16,182
+28.7%
0.02%
+25.0%
Q1 2018$554,000
-56.3%
12,572
-50.1%
0.02%
-48.7%
Q4 2017$1,268,000
+395.3%
25,214
+399.1%
0.04%
+254.5%
Q3 2017$256,0005,0520.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders